n ) was used to separate and identify related substances in ampicillin capsule. The fragmentation behaviors of related substances were used to identify their chemical structures. Finally, a total of 13 related substances in ampicillin capsule were identified, including four identified components for the first time and three groups of isomers on the basis of the exact mass, fragmentation behaviors, retention time, and chemical structures in the literature. This study avoided time-consuming and complex chemosynthesis of related substances of ampicillin and the results could be useful for the quality control of ampicillin capsule to guarantee its safety in clinic. In the meantime, it provided a good example for the rapid identification of chemical structures of related substances of drugs.
Introduction
Ampicillin is an important semisynthetic -lactam antibiotic and it is still widely used nowadays because of its good efficacy in urinary tract infections, respiratory infections, and other diseases caused by germs and bacteria. In recent years, the requirement of quality control for related substances in chemicals became stricter no matter in structure confirmation or content limitation. Ampicillin was especially degradable in presence of aqueous solution or humid storage environment, which would lead to the formation of a variety of degradation products [1] . These related substances (the related substances previously reported were shown in Table 1 ) would have a great influence on the quality of the products and clinical medication safety.
Although there has been much research on the related substances of ampicillin [2, 3] , it is not completely explicit so far. To ensure the clinical safety and meet the new requirement of related substances in chemicals [4] , it is still necessary to conduct further studies to develop a rapid and efficient method to describe in more detail the related substances of ampicillin capsule.
Many analytical methods including high-performance liquid chromatography (HPLC) [1, 5] , high-performance capillary electrophoresis (HPCE) [6] , high-performance liquid chromatography-atmospheric pressure chemical ionization mass (HPLC-APCI-MS) [7] , and high-performance liquid chromatography-electrospray mass spectrometry (HPLC-ESI-MS) [8, 9] had been utilized for the analysis of ampicillin. Among these methods, LC-ESI-MS had been shown to be a powerful technique for the analysis of ampicillin and its related substances due to its excellent ability in separation and identification.
In this paper, a simple, rapid, and sensitive Rapid Resolution Liquid Chromatography coupled with Electrospray Ionization Tandem Mass Spectrometry (RRLC-ESI-MS n ) method was established for the identification of the related substances in ampicillin capsule. The result suggested that this technique 1 6-Aminopenicillanic acid (6- 
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Journal of Analytical Methods in Chemistry 5 The chromatographic separation was performed with an Agilent 1200 series Rapid Resolution Liquid Chromatography system (Agilent Technologies, USA), equipped with a binary pump, a microvacuum degasser, a high-performance autosampler, a column compartment, a diode array detector, and a MS detector. The samples were separated on a 1.8 m Agilent Zorbax XDB-C 18 column (50 mm × 4.6 mm) at a flow rate of 0.4 mL⋅min −1 . The mobile phases consisted of 0.1% formic acid solution (A) and methanol (B). The optimized RRLC elution conditions were as follows: 0-2 min, 10% B; 2-10 min, 10-20% B; 10-20 min, 20-50% B; 20-25 min, 50% B; 25-25.1 min, 50-10% B; 25.1-30 min, 10% B. DAD spectra were acquired over a scan range of 190-400 nm. The sample volume injected was 1 L. Agilent 6320 mass spectrometer with an Agilent ChemStation to control and process the data was performed with the ESI source in positive ion mode. The vaporizer temperature was maintained at 300 ∘ C. The temperature of the drying gas was set at 350 ∘ C. The flow rate of the drying gas and the pressure of the nebulizing gas were set at 12 L⋅min −1 and 35 psi, respectively. The capillary voltage was kept at 3.5 × 10 3 V. The mass spectrometer scanned from a mass-to-charge ratio ( / ) 100-900.
Preparation of Sample.
The contents of ampicillin capsule (equivalent to 10 mg Ampicillin) were dissolved in 10 mL methanol and then filtered through a 0.22 m syringe filter. And an aliquot (1 L) of the filtrate was subjected to RRLC-ESI-MS n for analysis. 
Results and Discussion

Investigation of the Fragmentation Patterns of Ampicillin.
It was necessary to study the characterization of the mass spectra of the parent drug to identify the molecular structure of the related substances in ampicillin capsule. Identifications were based on the fact that the related substances of ampicillin usually contain structural fragments and analogous cleavage characteristic of the parent drug. Structural information and fragmentation mechanisms had been deduced from ions in the mass and collision spectra. This knowledge was useful in the analysis and identification of related substances in ampicillin capsule. We utilized knowledge of characteristic fragment ions of ampicillin and its related substances to identify their structures. Figures 1 and 2 showed the detailed total ion chromatography (TIC) and mass spectrum of ampicillin and its related substances, respectively. Ampicillin yielded an abundant ion in the ESI mass spectrum at / 350.1. The ESI mass spectrum of this ion ( / 350.1) was shown in Figure 2 . The fragment ions at / 106.2 and 160.0 were reported to arise from the benzylamine group and the thiazolidine ring. The fragment ion at / 192.0 was Intens.
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Intens.
Intens. proposed to arise as a result of losing a −NH 2 group at the benzylamine side chain followed by an oxygen rearrangement and cleavage of the -lactam ring. The fragment ion at / 174.0 could be attributed to the loss of H 2 O from the fragment at / 192.0, but it might arise from other pathways. The proposed fragmentation pathways of ampicillin were shown in Figure 3. 
Intens
Identification of the Known Related Substances in Ampicillin
Capsule. This part of the investigation focused on the characterization of the ESI-MS properties of the parent drug and its known related substances. [8] . Peak 3 showed the same fragment ions, fragmentation pattern, and characteristic ions as Peak 5. Therefore, we could conclude that Peak 3 was an isomer of Peak 5. Considering that Peak 3 had a much shorter retention time than Peak 5, and with the comparison of related substances reported in the literature [1] , Peak 3 was tentatively identified as L-ampicillin. Figure 5 showed the proposed MS fragmentation pathway for the fragmentation ions of L-ampicillin. [1] , Peak 6 was tentatively identified as (5R) or (5S) ampilloic acid. (5S) or (5R) ampilloic acids were the isomers of ampilloic acids which were reported to be metabolites or degradation products of ampicillin [1] . However, the exact structure of these two components could not be determined due to the limited information. Figure 6 showed the proposed MS fragmentation pathway for the fragmentation ions of ampilloic acids. was identified as closed-cycle trimer based on the published literature [1] . Closed-cycle trimer was also the main cause of allergy, so that we must control the amount of this related substance in ampicillin capsule. Ampicillin Capsule. This part of the investigation was to identify the chemical structures of unknown related substances which
Identification of the Unknown Related Substances in
were not yet reported in ampicillin capsule based on the mass fragment characterization and cleavage pathways of ampicillin and its known related substances. By means of the RRLC-ESI-MS n experiments, in this part, chemical structures of four related substances were tentatively identified in ampicillin capsule for the first time. Table 3 showed the chromatographic and mass spectral characteristics of the above unknown related substances detected by RRLC-ESI-MS n in ampicillin capsule. + . The fragment ion at / 191.0 probably should be a characteristic fragment ion of ampicillin piperazine-2,5-dione [12] . Thus, Peak 9 was identified tentatively as ampicilloic acid and 6-aminopenicillanic acid (6-APA) oligomer. Figure 9 showed the proposed MS fragmentation pathway for the fragmentation ion of ampicilloic acid and 6-APA oligomer.
Peak 12 produced a protonated molecular ion at /
[M + H]
+ and three major fragment ions at 443.1, 358.1, and 199.0. Based on fragment ions, Peak 12 was tentatively identified as 6-APA ampicillin amide. Figure 10 showed the proposed MS fragmentation pathway for the fragmentation ion of 6-APA ampicillin amide.
Peak 13 had a molecular weight of 673.2 [M + H] + and four major fragment ions / 655.1, 514.1, 324.1, and 191.0. The fragment ions at / 655.1 and 514.1 were attributed to the loss of one water molecule (18 Da) and one molecule of thiazolidine ring from ion at / 673.2. The fragment ion at / 324.1 was molecular weight of ampilloic acids. The fragment ion at / 191.0 was the fragment ion of ampicilloic acids. Peak 13 was identified tentatively as ampilloic acids and ampicilloic acids oligomer. Figure 11 showed the proposed MS fragmentation pathway for the fragmentation ion of ampilloic acids and ampicilloic acids oligomer.
Peak 14 produced a protonated molecular ion at /
+ , which was identified as the other isomer of
